Salient Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10,590
| Closed | -$768K | – | 60 |
|
|
2017
Q2 | $768K | Buy |
10,590
+30
| +0.3% | +$2.18K | 0.02% | 131 |
|
|
2017
Q1 | $688K | Sell |
10,560
-3,175
| -23% | -$207K | 0.01% | 157 |
|
|
2016
Q4 | $860K | Sell |
13,735
-513
| -4% | -$32.1K | 0.02% | 132 |
|
|
2016
Q3 | $899K | Buy |
14,248
+443
| +3% | +$28K | 0.02% | 122 |
|
|
2016
Q2 | $855K | Sell |
13,805
-456
| -3% | -$28.2K | 0.02% | 132 |
|
|
2016
Q1 | $815K | Sell |
14,261
-10,599
| -43% | -$606K | 0.02% | 134 |
|
|
2015
Q4 | $1.47M | Sell |
24,860
-19,842
| -44% | -$1.18M | 0.04% | 101 |
|
|
2015
Q3 | $2.43M | Sell |
44,702
-6,757
| -13% | -$368K | 0.06% | 91 |
|
|
2015
Q2 | $3.46M | Sell |
51,459
-5,503
| -10% | -$370K | 0.06% | 92 |
|
|
2015
Q1 | $3.34M | Sell |
56,962
-8,763
| -13% | -$513K | 0.06% | 88 |
|
|
2014
Q4 | $4.3M | Sell |
65,725
-2,228
| -3% | -$146K | 0.09% | 82 |
|
|
2014
Q3 | $3.93M | Buy |
67,953
+9,396
| +16% | +$543K | 0.07% | 92 |
|
|
2014
Q2 | $3.31M | Sell |
58,557
-6,618
| -10% | -$374K | 0.07% | 86 |
|
|
2014
Q1 | $3.35M | Buy |
65,175
+21,115
| +48% | +$1.09M | 0.09% | 74 |
|
|
2013
Q4 | $2.33M | Buy |
44,060
+13,095
| +42% | +$692K | 0.07% | 86 |
|
|
2013
Q3 | $1.39M | Buy |
30,965
+2,051
| +7% | +$91.7K | 0.06% | 92 |
|
|
2013
Q2 | $1.2M | Buy |
+28,914
| New | +$1.2M | 0.05% | 91 |
|